
Biyun Wang/LinkedIn
Dec 16, 2024, 11:38
18F-FES PET/CT Leading Precision Therapy for HR+/HER2- Breast Cancer – Mediamedic
Mediamedic shared a post on LinkedIn:
“Precision medicine is redefining breast cancer care.
At ESMOAsia2024, Professor. Biyun Wang of Fudan University Shanghai Cancer Center showcased how 18F-FES PET/CT is transforming first-line treatment for HR+/HER2- metastatic breast cancer. Her groundbreaking insights are paving the way for tailored therapies that truly make a difference.”
More posts featuring Mediamedic.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29